HROW

Harrow Inc — AI technical analysis, September 2026
NYSE/NASDAQ · Pharmaceuticals
AI Recommendation
HOLD
Technical score 50/100
Last price: $34.15  ·  52W range $28.54 – $54.85
Short answer

Should you buy HROW right now? Stockgaide's AI rates HROW as HOLD, with a technical score of 50/100 at a last price of $34.15. The 50-day average is below the 200-day average, and RSI sits at 29.0. Wall Street's consensus rating is 1.71/5.

Full AI analysis for HROW

Technical signal details

Rule-based read from price and momentum indicators only — the score behind the AI's recommendation above. Technical score: 50/100 (HOLD).

Technical indicators

RSI (14)
29.0
SMA 50
40.22
SMA 200
41.22
MACD hist
-0.398

Fundamentals & Wall Street

Market Cap
$1.28B
P/E (TTM)
Dividend Yield
Analyst Consensus
1.71 / 5

Analyst ratings: 13 Buy · 1 Hold · 0 Sell (1 = Strong Buy, 5 = Strong Sell)

HROW stock: frequently asked questions

Is HROW a buy right now?

Stockgaide's AI currently rates HROW as HOLD, with a technical score of 50 out of 100 at a last price of $34.15. This is educational content, not investment advice.

Is HROW in an uptrend?

HROW's 50-day moving average (40.22) is below its 200-day moving average (41.22), which points to a medium-term downtrend.

What is HROW's RSI today?

HROW has a 14-day RSI of 29.0, which places it in oversold territory (above 70 is overbought, below 30 is oversold).

What do analysts say about HROW?

Wall Street analysts covering HROW have a consensus rating of 1.71 out of 5 (1 = Strong Buy), meaning they lean Buy — 13 Buy · 1 Hold · 0 Sell.

Where is HROW trading in its 52-week range?

HROW last traded at $34.15, against a 52-week range of $28.54 to $54.85 — about 21% of the way up that range.

Get the full AI analysis of HROW

Price targets, fundamentals deep-dive and an AI-written report — free, no signup.

Analyze HROW now →
Data updated Sep 15, 2026 · refreshed daily